Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
ANAB
#1815
AnaptysBio, Inc. Common Stock
55.050
0
+1.79%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
+1.79%
Monatliche Änderung
+11.53%
6 month change
+56.39%
Jahresänderung
+56.39%
Vorheriger Schlusskurs
54.080
0
Open
55.050
0
Bid
Ask
Low
55.050
0
High
55.146
0
Volumen
74
Märkte
Aktien
Gesundheitswesen
ANAB
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
27.37 M
27.67 M
27.93 M
26.76 M
30.67 M
—
Valuation ratios
Enterprise value
337.92 M
465.89 M
744.84 M
544.79 M
282.95 M
2.05 B
Price to earnings ratio
—
-16.47
-6.39
-3.57
-2.59
-22.76
Price to sales ratio
—
15.09
80
34.05
4.12
19.36
Price to cash flow ratio
—
-20.76
-11.18
-4.84
-2.78
-18.76
Price to book ratio
—
2.67
3.14
6.63
5.3
40.34
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.05
0.09
0.21
0.36
0.3
0.3
Return on equity %
0.05
0.16
0.49
1.86
2.05
2.84
Return on invested capital %
238.66
409.35
360.61
619.98
899.03
708.52
Gross margin %
100
100
100
100
100
400
Operating margin %
31.84
89.93
1 119.41
958.27
125.93
284.62
EBITDA margin %
—
—
—
—
—
—
Net margin %
26.57
91.49
1 251.33
953.66
159.1
385.47
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
20.01
34.4
17.16
10.87
9.51
34.65
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.18
0.12
0.02
0.03
0.19
0.43
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0
—
—
—
—
—
Long term debt to total equity ratio
0
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
1.67
2.61
4.49
4.77
5.04
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
19.98
15.67
14.52
13.58
42.47
Net current asset value per share
—
20.19
15.88
15.11
15.22
48.59
Tangible book value per share
—
12.99
9.31
3.27
2.5
6.17
Working capital per share
—
19.6
14.95
13.72
13.62
43.01
Book value per share
—
12.99
9.31
3.27
2.5
6.17
Nachrichten
FDA akzeptiert Zulassungsantrag von Vanda für Medikament gegen seltene Hautkrankheit
FDA accepts Vanda’s imsidolimab application for rare skin disorder
AnaptysBio-Aktie erreicht 52-Wochen-Hoch bei 57,73 $
AnaptysBio stock hits 52-week high at $57.73
These IBD 50 Stocks Form Secondary Buy Areas, But Watch These Risks
AnaptysBio-Aktie erreicht 52-Wochen-Hoch von 52,56 $
AnaptysBio stock hits 52-week high at $52.56
Biotech Leader Eyes Spinoff Amid Massive Sales Surge
AnaptysBio: Direktorin verkauft Aktien im Wert von über 530.000 US-Dollar
AnaptysBio, Inc. (ANAB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
AnaptysBio-Aktie: UBS bestätigt Kaufempfehlung trotz Rechtsstreit mit GSK/n
AnaptysBio stock: UBS reiterates Buy rating amid ongoing GSK litigation